Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
87.40    2.10 (2.46%)
Bid:
87.00
Ask:
88.90
Spread: 1.90 (2.184%)
Market Cap: £367.39m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Acquisition

27 Sep 2010 07:00

RNS Number : 3178T
PZ CUSSONS PLC
27 September 2010
 

 

27 September 2010

 

PZ Cussons Plc

 

 

ACQUISITION OF ST TROPEZ HOLDINGS LIMITED

 

PZ Cussons Plc, a leading consumer products group in Europe, Asia and Africa, announces the acquisition of the entire issued share capital of St Tropez Holdings Limited ("St Tropez") from UK private equity group LDC for a consideration of £62.5m in cash (on a cash and debt free basis).

 

St Tropez is the UK's leading sunless tanning product range consisting of lotions, mousses, sprays and other products serving consumers who wish to achieve a safe, natural looking tan without the dangers of sun bathing or sun beds.

 

Over 80% of St Tropez's sales are within the UK with Australia and the US also growing markets for the brand. Distribution in the UK is mainly into Boots, Superdrug, Debenhams, Sainsbury's, House of Fraser and John Lewis, as well as through major salons.

 

St Tropez's retail product range comprises approximately 30 products organised across three core categories (Self Tan, Gradual Tan and Wash Off) and complemented by tan optimising products. All manufacturing is outsourced to third parties.

 

Revenue and earnings before depreciation, amortisation, interest and tax for the year ended 31 July 2010 were £20.7m and £7.4m respectively. As at 31 July 2010, St Tropez Holdings Limited had gross assets of £48.1m, including £42.1m of goodwill.

 

The business is being acquired on a cash and debt free basis from cash and existing facilities, and is expected to be earnings enhancing in the current financial year.

 

Alex Kanellis, Chief Executive of PZ Cussons Plc, said:

 

"The acquisition of the St Tropez brand represents an excellent strategic opportunity for PZ Cussons and further strengthens our portfolio of 'masstige' brands which includes The Sanctuary and Charles Worthington. We see good growth opportunities, both in the UK and overseas, particularly by linking the strategy to that of The Sanctuary spa brand.

 

Following this acquisition our balance sheet remains strong giving us flexibility for further investment opportunities as they arise."

 

Michelle Feeney, Chief Executive of St Tropez, said:

 

"I am thrilled that St Tropez is going into such a great home. PZ Cussons offers a synergistic opportunity for growth particularly in conjunction with The Sanctuary and will add the scaleability that the brand needs to become a truly international player."

 

 

- Ends -

 

 

An analyst's conference call will be hosted by Brandon Leigh, Finance Director, at 8:30am today. Please contact Giles Robinson at Hogarth on 020 7645 3988 for details.

 

 

For further information contact:

 

PZ Cussons Plc Tel: 0161 435 1016

Brandon Leigh

 

Hogarth Tel: 020 7357 9477

John Olsen

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQDQLFLBKFXBBE
Date   Source Headline
29th Nov 202111:25 amRNSDirector/PDMR Shareholding
25th Nov 20214:40 pmRNSDirector/PDMR Shareholding
23rd Nov 20214:05 pmRNSAnnual General Meeting
9th Nov 20217:00 amRNSDirector/PDMR Shareholding
15th Oct 20217:00 amRNSPublication of Annual Report and notice of AGM
24th Sep 20219:00 amRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSTrading Statement
22nd Sep 20217:00 amRNSFinal Results
13th Sep 20213:00 pmRNSAppointment of Non Executive Director
27th Jul 202111:00 amRNSDirector/PDMR Shareholding
5th Jul 20214:00 pmRNSDirector/PDMR Shareholding
1st Jul 20217:00 amRNSTrading update
29th Jun 202110:45 amRNSNotice of pre-close trading update
25th Jun 20217:00 amRNSAppointment of Non Executive Director
27th Apr 20217:00 amRNSTrading Statement
25th Mar 20217:00 amRNSCapital Markets Day
22nd Mar 20211:00 pmRNSDirector/PDMR Shareholding
22nd Feb 20215:30 pmRNSDirector/PDMR Shareholding
3rd Feb 20219:00 amRNSDirector/PDMR Shareholding
26th Jan 20217:00 amRNSHalf-year Report
1st Dec 20203:45 pmRNSDirector/PDMR Shareholding
26th Nov 20202:30 pmRNSResult of AGM
26th Nov 20207:00 amRNSDirectorate Change
23rd Oct 202012:00 pmRNSPublication of Annual Report / Notice of AGM
20th Oct 20201:00 pmRNSHolding(s) in Company
1st Oct 20208:38 amRNSCompletion of Nutricima disposal
28th Sep 20203:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20207:00 amRNSTrading Statement
23rd Sep 20207:00 amRNSBoard Change
23rd Sep 20207:00 amRNSFinal Results for the year ended 31 May 2020
14th Aug 20208:50 amRNSDirector Declaration
6th Jul 20209:05 amRNSDirector Declaration
30th Jun 20205:30 pmRNSDirector/PDMR Shareholding
19th Jun 20209:29 amRNSDirector/PDMR Shareholding
5th Jun 20202:15 pmRNSRevised reporting timetable
28th May 20201:01 pmRNSDirector/PDMR Shareholding
22nd May 202010:20 amRNSDirector Declaration
28th Apr 202011:33 amRNSDirector/PDMR Shareholding
16th Apr 20207:00 amRNSTrading Update for the Third Quarter 2020
14th Apr 20204:15 pmRNSBoard Change
2nd Apr 20207:00 amRNSUpdate on Settlement Agreement with Former CEO
19th Mar 20207:00 amRNSAppointment of new Chief Executive Officer
19th Mar 20207:00 amRNSBoard changes
18th Mar 20207:00 amRNSSale of Nutricima and completion of Luksja sale
20th Feb 20207:00 amRNSHolding(s) in Company
28th Jan 20207:00 amRNSHalf-year Report
12th Dec 20197:00 amRNSDirectorate Change
12th Dec 20197:00 amRNSTrading Update
30th Oct 20197:00 amRNSAppointment of Non-executive Directors
30th Sep 201911:15 amRNSCompletion of Minerva sale

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.